Conference Features

Program highlights

Specialist features

Explore the dedicated features associated with the event, from training and investment to international partnering and operational themes.

The features of a modern cell and gene therapy gathering are carefully shaped to reflect the maturity of the field, moving beyond traditional lecture formats into interactive spaces where science, business, and regulation meet. Specialized hubs allow attendees to step away from the main agenda and engage deeply with the themes most relevant to their work, whether that is translation, manufacturing, or clinical design. By grouping related discussions under clear thematic umbrellas, the event helps busy professionals navigate a complex landscape while still encouraging cross-disciplinary exchange between researchers, investors, and operational leaders.

Training has become a cornerstone feature for conferences serving the advanced therapies community, responding to the rapid expansion of techniques such as gene editing, viral vector production, and cell line engineering. A dedicated training course offers participants the chance to build practical understanding alongside the strategic conversations happening in the main program, bridging the gap between laboratory practice and commercial scale-up. This combination of structured learning and high-level dialogue supports teams at every stage, from early research groups to established developers refining their platforms.

Investment-focused programming has grown in importance as cell and gene therapies move closer to market, attracting interest from a wider range of financial and strategic backers. A dedicated investment portal within the event provides a focused environment for conversations between company leaders, venture investors, and corporate partners exploring collaborations. By concentrating these discussions in one space, the event helps streamline introductions, surface emerging opportunities, and encourage thoughtful capital deployment across a sector that often faces long development timelines and complex reimbursement questions.

International collaboration is increasingly central to the progress of advanced therapies, and partnering activities reflect the global nature of the community. Symposia focused on specific regions offer a structured way to explore regulatory environments, research priorities, and partnership opportunities in markets that may otherwise be difficult to access. These sessions, combined with open partnering spaces, encourage the kind of cross-border exchange that has historically accelerated innovation in biotech, allowing delegates to broaden their networks and align on shared scientific and commercial goals.